// App-Quantinova.ai

P-186 : Introduction of DYPD screening and its impact on treatment decisions: One centre's experience

Researchers

Presenter

  • A. Burnett

Principal Investigators

  • A. Dewdney

Medical Centers

  • Weston Park Hospital, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Dihydropyrimidine dehydrogenase deficiency

Biomarkers

  • Deoxypyridinoline

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved